Issues and Solutions in Psychiatric Clinical Trial with Case Studies

Area of Science:

• Psychiatry
• Neuroscience
• Clinical Research Methodology

Background:

• The COVID-19 pandemic significantly increased global rates of depression and anxiety disorders.
• Existing clinical interventions struggle to meet the escalating demand for mental health services.
• There is a critical need for rigorous, standardized clinical research in mental disorders.

Purpose of the Study:

• To identify challenges in clinical research for mental disorders, including study design, ethics, and efficacy evaluation.
• To propose improvements for more effective and safer mental health therapies.
• To address the limitations of subjective symptom presentation in diagnosis and research.

Main Methods:

• Analysis of challenges in study design, ethical considerations, sample selection, and efficacy evaluation.
• Review of diagnostic criteria and reliance on subjective symptom reporting.
• Exploration of multidisciplinary approaches and advanced research tools.

Main Results:

• Mental disorder diagnosis lacks clear biological standards, relying heavily on subjective measures.
• Psychotherapy shows potential for efficacy evaluation alongside pharmacotherapy.
• Current research methodologies face limitations in rigor and standardization.

Conclusions:

• A multidisciplinary approach involving psychiatrists, neuroscientists, and statisticians is recommended.
• Development of AI-integrated tools, biomarkers, and longitudinal designs is crucial for understanding mental disorders.
• International collaboration and diverse sampling are essential for improving research quality and findings' dependability.